Detalles de la búsqueda
1.
Nivolumab receptor occupancy on effector regulatory T cells predicts clinical benefit.
Cancer Sci
; 115(3): 752-762, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38254257
2.
Butyricimonas is a key gut microbiome component for predicting postoperative recurrence of esophageal cancer.
Cancer Immunol Immunother
; 73(2): 23, 2024 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38280026
3.
A high number of PD-L1+ CD14+ monocytes in peripheral blood is correlated with shorter survival in patients receiving immune checkpoint inhibitors.
Cancer Immunol Immunother
; 70(2): 337-348, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32757055
4.
Status of Natural Killer Cell Recovery in Day 21 Bone Marrow after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Clinical Outcome.
Biol Blood Marrow Transplant
; 24(9): 1841-1847, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29753837
5.
Association of Soluble Interleukin-2 Receptor and C-Reactive Protein with the Efficacy of Bendamustine Salvage Treatment for Indolent Lymphomas and Mantle Cell Lymphoma.
Acta Haematol
; 139(1): 12-18, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29301121
6.
Efficacy of palonosetron to prevent delayed nausea and vomiting in non-Hodgkin's lymphoma patients undergoing repeated cycles of the CHOP regimen.
Support Care Cancer
; 26(1): 269-274, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28766099
7.
[Syndrome of inappropriate secretion of antidiuretic hormone in multiple myeloma patients treated with bortezomib, lenalidomide, and dexamethasone combination therapy].
Rinsho Ketsueki
; 59(11): 2423-2427, 2018.
Artículo
en Japonés
| MEDLINE | ID: mdl-30531137
8.
Age and Bone Marrow Cellularity are Associated with Response to Eltrombopag in Japanese Adult Immune Thrombocytopenia Patients: A Retrospective Single-Center Study.
Rinsho Byori
; 63(5): 548-56, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26524893
9.
Agranulocytosis During Treatment With Sulfamethoxazole-Trimethoprim and a Proton Pump Inhibitor.
Am J Ther
; 28(6): e766-e768, 2019 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31833875
10.
Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody.
Sci Rep
; 14(1): 11325, 2024 05 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38760458
11.
Non-classical Monocytes Enhance the Efficacy of Immune Checkpoint Inhibitors on Colon Cancer in a Syngeneic Mouse Model.
Anticancer Res
; 44(1): 23-29, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38159965
12.
Case Report: Combined pembrolizumab, 5-fluorouracil, and cisplatin therapy were remarkably effective in p16-positive squamous cell carcinoma of unknown primary.
Front Oncol
; 13: 1231986, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37496666
13.
Monocyte subsets associated with the efficacy of antiPD1 antibody monotherapy.
Oncol Lett
; 26(3): 381, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37559573
14.
Turicibacter and Acidaminococcus predict immune-related adverse events and efficacy of immune checkpoint inhibitor.
Front Immunol
; 14: 1164724, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37207204
15.
Novel quantitative immunohistochemical analysis for evaluating PD-L1 expression with phosphor-integrated dots for predicting the efficacy of patients with cancer treated with immune checkpoint inhibitors.
Front Immunol
; 14: 1260492, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37790929
16.
CD20 gene deletion causes a CD20-negative relapse in diffuse large B-cell lymphoma.
Eur J Haematol
; 89(4): 350-5, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22805426
17.
A case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer: A case report.
Medicine (Baltimore)
; 101(2): e28339, 2022 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35029177
18.
[Bilateral renal infiltration of acute lymphoblastic leukemia cells at relapse after allogeneic stem cell transplantation].
Rinsho Ketsueki
; 52(12): 1882-7, 2011 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-22241156
19.
The Prognostic Impact of Eosinophils and the Eosinophil-to-Lymphocyte Ratio on Survival Outcomes in Stage II Resectable Pancreatic Cancer.
Pancreas
; 50(2): 167-175, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33565793
20.
Minimal contribution of the hepatic uptake transporter OATP1B1 to the inter-individual variability in SN-38 pharmacokinetics in cancer patients without severe renal failure.
Cancer Chemother Pharmacol
; 88(3): 543-553, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34117512